Acronyms and abbreviations
Agency for Healthcare Research and Quality (United States)
Agenzia Italiana del Farmaco (Italian Medicines Agency)
Advance market commitment
Anti-microbial resistance
Asia-Pacific Economic Cooperation - Life Sciences Innovation Forum
United States Census Annual Survey of Manufacturing
Average sales price (United States)
Australian dollars
Zidovudine also known as azidothymidine
Business Enterprise Expenditure on R&D
Business R&D and Innovation Survey
Capital Asset Pricing Model
Cancer Drug Fund (United Kingdom)
Cost effectiveness analysis
Coverage with evidence development
Central & Eastern European Society of Technology Assessment in Health Care
Comité économique des produits de santé (Economic Committee for Health Products, France)
Chronic myeloid leukaemia
Centers for Medicare & Medicaid Services (United States)
Cost of Equity
Cost of Capital
Core Outcome Measures in Effectiveness Trials
Committee on Orphan Medicinal Products (EMA)
Direct acting anti-viral
Disability-Adjusted Life Years
Defined daily dose
Biological Disease-Modifying Anti-Rheumatic Drug
Disease Modifying Therapy
Drugs for Neglected Diseases Initiative
Diagnosis-related group
Eastern Caribbean Drug Service
European Economic Area
European Federation of Pharmaceutical Industries & Associations
Electronic health record
Electronic Health Records Research Group
European Medicines Agency
European Society for Medical Oncology
End stage renal disease
European Union
European Network for Health Technology Assessment
Euro
Food & Drug Administration (US)
Fee for Service
Fondo de Solidaridad y Garantia (Colombian Solidarity and Guarantee Fund)
Full-time equivalents
Pounds Sterling
Gulf Cooperation Council / Group Purchasing Program
Global Drug Facility
Gross domestic product
Global Industry Classification Standard
General practitioner
Gross value added
Haute Autorité de Santé (France)
Hepatitis C virus
Human immunodeficiency virus/acquired immunodeficiency syndrome
Horizon scanning
Health technology assessment
Health Technology Assessment International
Incremental cost-effectiveness ratio
International Conference on Harmonization
Information and communications technology
International Clinical Trials Registry Platform
International Generic Drug Regulators Programme
Italian Horizon Scanning Project
Innovative Medicines Initiative
International Network of Agencies for Health Technology Assessment
International non-proprietary name
International Pharmaceutical Regulators Programme
Federaal Kenniscentrum voor de gezondheidszorg (Belgian Healthcare Knowledge Centre)
Least costly alternative
Legemiddleinnkjøpssamarbeid (Norwegian Drug Procurement Cooperation)
Low- and middle-income countries
Loss of exclusivity
Life Saving Drugs Program (Australia)
Medicare Advantage - Prescription Drug plan (United States)
Multi-criteria decision analysis
Managed entry agreement
Medicines Patent Pool
Medical Research Future Fund (Australia)
North American Industry Classification System
New active substance
New chemical entity
New drug approval
Non-government organisation
National Health Service (United Kingdom)
National Institute for Health & Care Excellence (United Kingdom)
National Institutes of Health (United States)
National Institute for Health Research (United Kingdom)
New molecular entity
Norwegian Krone
Net present value
National Science Foundation
Neglected tropical disease
Organisation for Economic Co-operation & Development
Office of Fair Trading (United Kingdom)
Observational Health Data Sciences and Informatics
Orphan medical products
Over the counter
Pharmacy and therapeutics
Pay for performance
Pulmonary arterial hypertension
Pan American Health Organisation
Pan American Network for Drug Regulatory Harmonization
Policy and Regulatory Report database
Pharmaceutical Benefits Advisory Committee (Australia)
Pharmacy benefit manager
Pharmaceutical Benefits Scheme (Australia)
Pharmaceutical Research and Manufacturers of America
Pharmaceuticals & Medical Devices Agency (Japan)
Product development partnership
Progression-free survival
Public-private partnership
Pharmaceutical Pricing & Reimbursement Information
Pharmaceutical Price Regulation Scheme (United Kingdom)
Quality-Adjusted Life Year
Research and development
Randomised controlled trial
Red de Evaluación de Tecnologías en Salud de Las Américas (Health Technology Assessments Network for the Americas)
Request for proposal
Request for tender
Return on assets
Swedish Krona
Small and medium-sized enterprises
System of National Accounts
sofosbuvir /ledipasvir
sofosbuvir/velpatasvir
Special protocol assessment
Stringent regulatory agency
Systematic Review Data Repository
Structural Analysis
Sustained viral response
Treaty on the Functioning of the European Union
Tyrosine kinase inhibitor
The National Dental and Pharmaceutical Benefits Agency (Sweden)
Tumour necrosis factor
United Kingdom Prospective Diabetes Study
United States dollars
Voluntary health insurance
Wholesale acquisition cost (United States)
World Health Organization
World Intellectual Property Organization
World Trade Organization